Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
50 studies found for:    Open Studies | Prenatal Exposure OR Exposure During Pregnancy OR Teratogenesis
Show Display Options
Rank Status Study
21 Recruiting VIBATIV Pregnancy Registry
Condition: Pregnancy
Intervention: Drug: VIBATIV
22 Not yet recruiting Vascular Responses to UV Exposure in Pregnancy
Condition: Pregnancy
Interventions: Radiation: UVA radiation;   Radiation: Sham Control
23 Recruiting Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Conditions: Meningococcal Disease;   Pregnancy
Intervention: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine
24 Recruiting Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero
Conditions: Pregnancy;   Gestational Diabetes Mellitus
Intervention:
25 Not yet recruiting Respiratory Syncytial Virus (RSV) and Vaccination in Pregnancy
Conditions: Respiratory Syncytial Virus (RSV);   Maternal Vaccine Exposure;   Attitude
Intervention: Other: Questionnaire
26 Not yet recruiting Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns
Conditions: Pregnancy Related;   Tobacco Smoking;   Lung Smokers;   Newborn
Interventions: Diagnostic Test: lung function tests;   Diagnostic Test: Nasal brushing
27 Not yet recruiting Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep
Condition: Sleep Disturbance
Interventions: Device: Blue-blocking glasses;   Device: Light grey control glasses
28 Recruiting Pregnancy Registry Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fingolimod
29 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
30 Recruiting OTIS Autoimmune Diseases in Pregnancy Project
Conditions: Crohn's Disease;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
31 Recruiting Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
Conditions: Depressive Disorder;   Lactation
Intervention: Drug: SSRI/SNRI
32 Recruiting Option B+: Study on Safety, Viral Suppression, and Survival on Second Line ART
Conditions: HIV;   Infant Exposure to Efavirenz
Intervention:
33 Recruiting Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
Conditions: HIV/AIDS;   Antiretroviral Therapy;   Pregnancy Outcomes;   HIV-exposed Infants
Intervention: Other: Continuous quality improvement
34 Recruiting Analysis of Toxins in Follicle Fluid
Conditions: Environmental Exposure to Harmful Algae and Toxins;   Female Subfertility
Intervention:
35 Recruiting Pregnancy Environment and Newborn Malformations
Condition: Congenital Malformation
Intervention: Other: meconium samples + maternal self-questionnaire
36 Recruiting Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Conditions: Microcephaly;   Mental Retardation
Intervention: Other: Symptomatic pregnant women with positive RT-PCR ZIKV in serum or urine, or a positive serologic test specific for ZIKV
37 Recruiting Prenatal Alcohol Biomarker Study in Uruguay
Condition: Fetal Alcohol Syndrome
Intervention:
38 Recruiting A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell Tumor
Condition: Testicular Germ Cell Tumor
Intervention: Other: Phone interview and blood test
39 Recruiting Yervoy Pregnancy Surveillance Study
Condition: Melanoma
Intervention: Drug: Yervoy
40 Recruiting EPID Multiple Sclerosis Pregnancy Study
Condition: Multiple Sclerosis
Interventions: Drug: Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG;   Drug: Extavia (interferon beta-1b), Novartis Pharma AG;   Drug: Rebif (interferon beta-1a), Merck Serono Europe Ltd;   Drug: Plegridy (peginterferon beta-1a), Biogen Idec Ltd;   Drug: Avonex (interferon beta-1a), Biogen Idec Ltd;   Drug: MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046);   Other: No MSDMDs therapy (control)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.